Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
13.40
-0.51 (-3.67%)
Mar 3, 2026, 4:00 PM EST - Market closed
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $408.25 million as of March 3, 2026. Its market cap has decreased by -2.34% in one year.
Market Cap
408.25M
Enterprise Value
-267.80M
1-Year Change
-2.34%
Ranking
Category
Stock Price
$13.40
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $408.25M, an increase of 5.95%. That is a compound annual growth rate of 0.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 408.25M | -34.18% |
| Dec 31, 2025 | 620.29M | -3.27% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immix Biopharma | 440.53M |
| Tectonic Therapeutic | 431.86M |
| LENZ Therapeutics | 428.05M |
| Enanta Pharmaceuticals | 421.07M |
| Absci | 421.04M |
| Entrada Therapeutics | 420.48M |
| Anavex Life Sciences | 419.80M |
| DiaMedica Therapeutics | 416.84M |